Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial. uri icon

authors

  • Papp, K V
  • Ernstrom, K
  • Raman, R
  • Aisen, P S
  • Reisa Sperling, MD
  • Romano, G
  • Henley, D
  • Rofael, H
  • Veroff, A E
  • Donohue, M C
  • Wang, S
  • Randolph, C
  • Grober, E
  • Brashear, H R
  • Novak, G

publication date

  • 2022